UAE (United Arab Emirates) is attracting a newer Industry like clinical trials to its base and is creating a paradigm shift from the developing countries. This shift has been slow paced, yet remarkable. The scenario was initiated with top 10 pharmaceutical companies establishing themselves in this region and making their presence felt. Following this the big contract research organizations have followed the trend.
Many of the newer contract research organizations (CROs) with presence outside the gulf region are now making their entry to UAE with few older pre-existing CROs, who are already reaping the benefits of being the first contract research players in this region. Coupled with large pharma base these CROs are creating a safer and friendlier market which happens to have its own advantages.
The regulatory environment in UAE is cooperative with respect to its acceptance of continuation of studies conducted abroad as long as the data is appropriately validated. The fast track approval for clinical trials from the UAE regulators is bliss for CROs as well. Also compliance with ICH-GCP guidelines (International Council on Harmonisation Good Clinical Practice) makes the existing data reliable for the sponsors who outsource this clinical research work as they are continuously monitored by stiff regulators like US FDA.
CROs in UAE are offering full time services like project management, data management, regulatory affairs consulting, etc. Clinical research Industry is always in search of expert human resources who are skilled, knowledgeable and trained professionals. This has opened up numerous opportunities for freshers in UAE, especially Dubai to make a career and grow in this clinical research industry.